Geron Q4 2017 Earnings Conference Call Suggests That Imetelestat, Currently Undergoing Clinical Trials, May Be Shown Useful In Treating And Extending The Life Of Those Diagnosed With At Least Some Form Of Cancer

Geron Q4 2017 Earnings Conference Call (broadcast yesterday, see https://ir.geron.com/phoenix.zhtml?c=67323&p=irol-news&nyo=0; obtained on 3-20-2018) Suggests That Imetelestat, Currently Undergoing Clinical Trials,  May Be Shown…

Read more